Cytodyn Inc (CYDY)

[Saltz]

The next raise coming up will be small. Just enough to bridge to P3 Combo PE data. That means one month after enrollment has been completed because it will take one month to compile data. The value and derisking of Pro-140 at that juncture will dramatically increase options for the major raise. The timing for that tipping point is end of July-August. That is IMO a defining point in time for Pro-140.

Currently all resources and energy is on completing enrollment of the Combo. We are nearing the finish line. I believe they have the final patients in testing at this moment. We have to put into perspective the purpose of the Combo trial - a requirement by the FDA for Pro-140's Mono pathway. Mark my words the P3 Mono enrollment WILL fly once Combo enrollment is complete. They strongly believe they will enroll 300 patients by year end. Keep in mind this is on Tony's watch now and his timelines.

Once Combo PE data is PR'd the landscape changes in a big way. Many new options and possible deals will surface and that is where Tony C's experience comes in. You can bet he is licking his chops and setting the stage right now because he knows how strong the data will be. They know how disruptive the science is and know they just need to produce the data. It's coming in a few months. Only news between now and then is how they will put together the small raise to get Pro-140 to the data.